Prime brokerage on Currenex by close of year

Currenex, the online global currency exchange, will make available prime brokerage services to members of its FXtrades forex platform by the close of 2001, according to Lori Mirek, the firm’s New York-based president and chief executive officer.

“The constraint of requiring a credit counterparty relationship to be in place before a fund or corporate can transact with a bank has limited liquidity in forex up until now, but we are about to change all that,” said Mirek. A number of banks, including ABN Amro, Barclays Capital, Standard Chartered and Lehman Brothers, have already signed-up to provide the prime broker role on Currenex’s forthcoming enhanced market access (EMA) facility.

Corporate, traditional fund and hedge fund clients currently trading via Currenex have potential counterparty lists that only include the names of dealers with which they have established credit lines. “The client may only have the resources or appetite to manage, for example, a dozen credit counterparty relationships – so there’s a real limitation in terms of it getting the best quote for a trade,” said Mirek.

EMA will overcome this natural limitation by supplementing the normal counterparty list with a number of prime brokers, or ‘hub’ banks – effectively loaning their own inter-bank credit lines to the client.

“EMA takes online forex trading one step further. A multinational corporate will be able to get many more quotes without establishing more credit relationships, and can streamline the clearing and settlement of trades,” said David Blair, managing director of Nokia Treasury Asia.

Later on, credit brokers, banks that do not quote forex prices or do clearing or settlement, but simply guarantee credit between the buy side and sell side for a fee – will be introduced onto the service by the end of the second quarter of 2002, said Mirek.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here